世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

自動細胞計数装置の市場規模、シェア、動向分析レポート:製品別(装置、消耗品、付属品)、用途別(血液分析、幹細胞研究)、最終用途別、地域別、セグメント別予測、2024年~2030年


Automated Cell Counting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories), By Application (Blood Analysis, Stem Cell Research), By End-use, By Region, And Segment Forecasts, 2024 - 2030

自動細胞計数市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界の自動細胞計数市場規模は2030年までに89億3000万米ドルに達し、2024年から2030年までのCAGRは12.45%を記録すると予測... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年12月4日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
110 英語

1~3営業日


 

サマリー

自動細胞計数市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の自動細胞計数市場規模は2030年までに89億3000万米ドルに達し、2024年から2030年までのCAGRは12.45%を記録すると予測されている。慢性疾患や感染症の予防と治療における生物製剤のニーズの高まり、バイオテクノロジー&バイオ医薬品産業への投資の増加、高度な細胞ベースの研究開発が市場拡大の要因の一部である。生物製剤の開発では、生物製剤中の細胞濃度を管理するために、画像ベースのカウンターやフローサイトメーターなど、さまざまな細胞計数装置の使用が必要となるため、市場の成長見通しを後押ししている。

COVID-19パンデミックは、細胞計数装置や消耗品の利用に多大な影響を与えた。パンデミックでは、骨減少症やリンパ球減少症がCOVID-19の指標となる可能性があったため、細胞計数機器の使用が増加した。例えば、2021年6月、学術誌『BMC Infectious Diseases』に掲載された研究では、入院時の白血球数の多さがCOVID-19患者の死亡と大きく関連していることが発見された。その結果、COVID-19を治療する際には、より多くの白血球数が考慮されるようになった。このような進展により、COVID-19の流行は市場の成長に大きな影響を与えた。

HIV、麻疹、ジフテリアなどの対象疾患、がんやその他の血液疾患などの慢性疾患の発生率の増加、高スループットフローサイトメトリーや自動血液分析装置の利用率の増加が市場拡大の主な要因である。UNAIDSのデータによると、2022年には全世界で推定3,840万人がHIVに感染し、2021年には推定150万人が新たにHIVに感染した。その結果、感染症患者の増加が細胞計数機器と消耗品の需要を押し上げる可能性が高い。

例えば、Mindrayは2022年3月に新しいBC-700シリーズを発表した。BC-700シリーズは、赤血球沈降速度(ESR)測定とともに全血球算定(CBC)を含む革新的な血液学分析装置シリーズである。こうして市場の成長を後押ししている。

同市場は、幹細胞、癌、免疫学研究のための政府や民間投資の増加から恩恵を受けている。自動計数技術は、表現型同定、細胞ソーティング、単細胞分析などの用途で、細胞生物学やゲノミクス研究を推進する助成金プログラムに使用されている。例えば、米国国立衛生研究所(NIH)は、2021年に410億ドル以上の医療研究資金を全米の大学や研究所に交付したが、そのうちのかなりの割合が細胞ベースの研究プログラムに割り当てられた。このように、このような資金と資金が利用可能であるため、研究室はハイエンドの自動細胞分析ツールを入手することができ、市場の成長をさらに後押しする。

自動細胞計数市場レポートハイライト

- 製品別では、消耗品とアクセサリーの分野が予測期間中に最も速いCAGRを示すと予測されている。自動細胞計数器用消耗品および付属品の度重なる調達により市場は拡大している

- アプリケーション別では、幹細胞研究分野が予測期間中に最も速い成長が見込まれる。医療関係者や研究者による幹細胞研究や医薬品開発の増加が、世界市場の成長を促進すると予想される。

- 最終用途別では、病院・診断検査分野が予測期間中に最も急成長する見込みである。慢性疾患の有病率の増加、老人人口の増加、その他

- 北米は2023年に最大の収益シェアを占めた。これは、主要な市場参加者が存在すること、米国などにおける医療費の上昇がこの地域の市場を押し上げていることが主な要因である。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Application Segment
1.2.3. End-user Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing prevalence of chronic diseases
3.3.2. Technological advancements in cell counting instruments
3.3.3. Increasing government funding for cell-based research
3.4. Market Restraint Analysis
3.4.1. High costs of advanced cell counting systems
3.4.2. Low adoption in underdeveloped regions
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Global Automated Cell Counting Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.2.2. Flow Cytometers
4.2.2.1. Flow Cytometers Market, 2018 - 2030 (USD Million)
4.2.3. Image-based Cell Counters
4.2.3.1. Image-based Cell Counters Market, 2018 - 2030 (USD Million)
4.2.4. Electrical Impendence Coulter Counters
4.2.4.1. Electrical Impendence Coulter Counters Market, 2018 - 2030 (USD Million)
4.3. Consumables & Accessories
4.3.1. Consumables & Accessories Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Global Automated Cell Counting Market: Application Movement Analysis
5.2. Blood Analysis
5.2.1. Blood Analysis Market, 2018 - 2030 (USD Million)
5.3. Stem Cell Research
5.3.1. Stem Cell Research Market, 2018 - 2030 (USD Million)
5.4. Cell Line development
5.4.1. Cell Line development Market, 2018 - 2030 (USD Million)
5.4.2. Biologics Production
5.4.2.1. Biologics Production Market, 2018 - 2030 (USD Million)
5.4.3. Cell & Gene Therapy
5.4.3.1. Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. End-Use Business Analysis
6.1. Global Automated Cell Counting Market: End-use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.3. Hospitals & Diagnostic laboratories
6.3.1. Hospitals & Diagnostic laboratories Market, 2018 - 2030 (USD Million)
6.4. Research & Academic Institutes
6.4.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Global Automated Cell Counting Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Target Disease Prevalence
7.2.2.4. U.S. Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Target Disease Prevalence
7.2.3.4. Canada Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Target Disease Prevalence
7.3.2.4. Germany Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Target Disease Prevalence
7.3.3.4. UK Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Target Disease Prevalence
7.3.4.4. France Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Target Disease Prevalence
7.3.5.4. Italy Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Target Disease Prevalence
7.3.6.4. Spain Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Target Disease Prevalence
7.3.7.4. Denmark Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Target Disease Prevalence
7.3.8.4. Sweden Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Target Disease Prevalence
7.3.9.4. Norway Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Target Disease Prevalence
7.4.2.4. Japan Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Target Disease Prevalence
7.4.3.4. China Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Target Disease Prevalence
7.4.4.4. India Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Target Disease Prevalence
7.4.5.4. South Korea Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Target Disease Prevalence
7.4.6.4. Australia Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Target Disease Prevalence
7.4.7.4. Thailand Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Target Disease Prevalence
7.5.2.4. Brazil Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Target Disease Prevalence
7.5.3.4. Mexico Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Target Disease Prevalence
7.5.4.4. Argentina Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Target Disease Prevalence
7.6.2.4. South Africa Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Target Disease Prevalence
7.6.3.4. Saudi Arabia Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Target Disease Prevalence
7.6.4.4. UAE Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Target Disease Prevalence
7.6.5.4. Kuwait Automated Cell Counting Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market/Position Share Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Countstar, Inc.
8.4.2.1. Overview
8.4.2.2. Product Benchmarking
8.4.2.3. Strategic Initiatives
8.4.3. Bio-Rad Laboratories, Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. F. Hoffmann-La Roche Ltd
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Chemometec A/S
8.4.5.1. Overview
8.4.5.2. Product Benchmarking
8.4.5.3. Strategic Initiatives
8.4.6. Danaher
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Olympus Corporation
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Merck KGaA
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Sysmex Corporation
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Agilent Technologies, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Abbott
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives

 

ページTOPに戻る


 

Summary

Automated Cell Counting Market Growth & Trends

The global automated cell counting market size is expected to reach USD 8.93 billion by 2030, registering a CAGR of 12.45% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing need for biologics in the prevention and treatment of chronic and infectious diseases, increased investment in the biotechnology & biopharmaceutical industries, and the development of advanced cell-based research are some of the factors driving market expansion. Biologics development necessitates the use of various cell counting equipment, including image-based counters and flow cytometers, to manage cell concentration in biologics, hence boosting the market's growth prospects.

The COVID-19 pandemic had an enormous impact on the utilization of cell-counting equipment and consumables. The pandemic saw an increase in the use of cell counting instruments, as osteopenia & lymphopenia were possible COVID-19 indicators. For instance, in June 2021, a study published in the journal BMC Infectious Diseases discovered that a high number of white blood cells upon admission was substantially associated with death in COVID-19 individuals. As a result, a greater number of white blood cells were taken into account when treating COVID-19. Due to such developments, the COVID-19 outbreak had a significant impact on the market growth.

The increased incidence of target diseases such as HIV, measles, diphtheria, & chronic diseases such as cancer and other blood disorders, as well as the increasing utilization of high-throughput flow cytometry & automated hematology analyzers, are the primary factors driving market expansion. According to UNAIDS data, an estimated 38.4 million individuals worldwide were living with HIV in 2022, while an estimated 1.5 million were newly infected with HIV in 2021. As a result, growing infectious illness cases are likely to drive up demand for cell counting instruments and consumables.

Increasing initiatives by leading market players to create improved cell counter devices have resulted in increased popularity of these products due to their numerous applications and ease of use. for example, Mindray introduced the new BC-700 Series in March 2022, an innovative hematology analyzer series that includes complete blood count (CBC) along with erythrocyte sedimentation rate (ESR) assays. Thus, boosting the market growth.

The market is benefiting from increased government & private investment for stem cell, cancer, & immunology research. Automated counting technologies are used in grant programs to advance cell biology and genomics research for applications such as phenotypic identification, cell sorting, as well as single cell analysis. For example, the National Institutes of Health (NIH) granted over $41 billion in healthcare research funding to universities and labs across the US in 2021, a substantial percentage of which was allocated to cell-based research programs. Thus, the availability of such funds and funding enables labs to obtain high-end automated cell analysis tools and further boost market growth.

Automated Cell Counting Market Report Highlights

• Based on product, the consumables and accessories segment is expected to witness the fastest CAGR during the forecast period. The market is expanding due to the repeated procurement of consumables and accessories for automated cell counters

• Based on application, the stem cell research segment is expected to witness the fastest growth during the forecast period. Increased stem cell research and drug development by medical professionals as well as researchers is expected to fuel global market growth

• Based on end-use, the hospitals & diagnostic laboratories segment is expected to witness the fastest growth during the forecast period. The growing prevalence of chronic disorders, the rising number of geriatric population, and others

• North America held the largest revenue share in 2023. This is mostly due to the presence of major market participants and, the rising cost of healthcare in the U.S. and others, which is driving up the market for this region



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Application Segment
1.2.3. End-user Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing prevalence of chronic diseases
3.3.2. Technological advancements in cell counting instruments
3.3.3. Increasing government funding for cell-based research
3.4. Market Restraint Analysis
3.4.1. High costs of advanced cell counting systems
3.4.2. Low adoption in underdeveloped regions
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Global Automated Cell Counting Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.2.2. Flow Cytometers
4.2.2.1. Flow Cytometers Market, 2018 - 2030 (USD Million)
4.2.3. Image-based Cell Counters
4.2.3.1. Image-based Cell Counters Market, 2018 - 2030 (USD Million)
4.2.4. Electrical Impendence Coulter Counters
4.2.4.1. Electrical Impendence Coulter Counters Market, 2018 - 2030 (USD Million)
4.3. Consumables & Accessories
4.3.1. Consumables & Accessories Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Global Automated Cell Counting Market: Application Movement Analysis
5.2. Blood Analysis
5.2.1. Blood Analysis Market, 2018 - 2030 (USD Million)
5.3. Stem Cell Research
5.3.1. Stem Cell Research Market, 2018 - 2030 (USD Million)
5.4. Cell Line development
5.4.1. Cell Line development Market, 2018 - 2030 (USD Million)
5.4.2. Biologics Production
5.4.2.1. Biologics Production Market, 2018 - 2030 (USD Million)
5.4.3. Cell & Gene Therapy
5.4.3.1. Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. End-Use Business Analysis
6.1. Global Automated Cell Counting Market: End-use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.3. Hospitals & Diagnostic laboratories
6.3.1. Hospitals & Diagnostic laboratories Market, 2018 - 2030 (USD Million)
6.4. Research & Academic Institutes
6.4.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Global Automated Cell Counting Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Target Disease Prevalence
7.2.2.4. U.S. Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Target Disease Prevalence
7.2.3.4. Canada Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Target Disease Prevalence
7.3.2.4. Germany Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Target Disease Prevalence
7.3.3.4. UK Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Target Disease Prevalence
7.3.4.4. France Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Target Disease Prevalence
7.3.5.4. Italy Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Target Disease Prevalence
7.3.6.4. Spain Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Target Disease Prevalence
7.3.7.4. Denmark Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Target Disease Prevalence
7.3.8.4. Sweden Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Target Disease Prevalence
7.3.9.4. Norway Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Target Disease Prevalence
7.4.2.4. Japan Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Target Disease Prevalence
7.4.3.4. China Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Target Disease Prevalence
7.4.4.4. India Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Target Disease Prevalence
7.4.5.4. South Korea Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Target Disease Prevalence
7.4.6.4. Australia Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Target Disease Prevalence
7.4.7.4. Thailand Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Target Disease Prevalence
7.5.2.4. Brazil Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Target Disease Prevalence
7.5.3.4. Mexico Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Target Disease Prevalence
7.5.4.4. Argentina Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Target Disease Prevalence
7.6.2.4. South Africa Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Target Disease Prevalence
7.6.3.4. Saudi Arabia Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Target Disease Prevalence
7.6.4.4. UAE Automated Cell Counting Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Target Disease Prevalence
7.6.5.4. Kuwait Automated Cell Counting Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market/Position Share Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Countstar, Inc.
8.4.2.1. Overview
8.4.2.2. Product Benchmarking
8.4.2.3. Strategic Initiatives
8.4.3. Bio-Rad Laboratories, Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. F. Hoffmann-La Roche Ltd
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Chemometec A/S
8.4.5.1. Overview
8.4.5.2. Product Benchmarking
8.4.5.3. Strategic Initiatives
8.4.6. Danaher
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Olympus Corporation
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Merck KGaA
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Sysmex Corporation
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Agilent Technologies, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Abbott
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

Grand View Research社の生物分野での最新刊レポート

本レポートと同じKEY WORD(consumables)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る